Fax: (011) 39-02-23903656
Supplement
Predictive models in palliative care†
Article first published online: 19 JUN 2009
DOI: 10.1002/cncr.24351
Copyright © 2009 American Cancer Society
Issue
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470)
Cancer
Supplement: Predictive Modeling in Prostate Cancer, Supplement to Cancer
Volume 115, Issue Supplement 13, pages 3128–3134, 1 July 2009
Additional Information
How to Cite
Ripamonti, C. I., Farina, G. and Garassino, M. C. (2009), Predictive models in palliative care. Cancer, 115: 3128–3134. doi: 10.1002/cncr.24351
- †
Presented at the Inside Track Conference “Predictive Modeling in Prostate Cancer,” organized by the European School of Oncology, Venice, Italy, April 17-19, 2008.
- ‡
Fax: (011) 39-02-23903656
Publication History
- Issue published online: 19 JUN 2009
- Article first published online: 19 JUN 2009
- Manuscript Accepted: 11 FEB 2009
- Manuscript Revised: 2 FEB 2009
- Manuscript Received: 22 SEP 2008
Funded by
- ASTRA Zeneca
- European School of Oncology
- Abstract
- Article
- References
- Cited By
Keywords:
- prostate cancer;
- palliative care;
- prediction;
- prognostic factors
Abstract
It is important to identify prognostic and predictive factors concerning both life expectancy and quality of life in palliative care patients to facilitate ethical, clinical, and organizational decisions, but also to use resources in the best possible way. The authors reviewed the literature to identify the major factors that can predict survival of patients with solid tumors. They found only a few prospective assessments of prognostic factors. Clinical prognostic/predictors of survival based on physician's and/or nurse's judgment, performance status, dyspnea at rest, anorexia, dysphagia, or delirium are all considered to be of primary importance. Despite several contrasting findings, it is generally agreed that the type and site of the primary tumor and metastasis, psychosocial factors, and quality of life should be considered secondary to the organic effects in the final stages of life. Leukocytosis, lymphocytopenia, and elevated C-reactive protein are all reported to have prognostic significance, and low serum albumin and high lactate dehydrogenase levels must also be taken into consideration. Cancer 2009;115(13 suppl):3128–34. © 2009 American Cancer Society.

1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)